Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;113(2):e35530.
doi: 10.1002/jbm.b.35530.

Microfluidics Based Particle and Droplet Generation for Gene and Drug Delivery Approaches

Affiliations
Review

Microfluidics Based Particle and Droplet Generation for Gene and Drug Delivery Approaches

Deniz Onan et al. J Biomed Mater Res B Appl Biomater. 2025 Feb.

Abstract

Microfluidics-based droplets have emerged as a powerful technology for biomedical research, offering precise control over droplet size and structure, optimal mixing of solutions, and prevention of cross-contamination. It is a major branch of microfluidic technology with applications in diagnostic testing, imaging, separation, and gene amplification. This review discusses the different aspects of microfluidic devices, droplet generation techniques, droplet types, and the production of micro/nano particles, along with their advantages and limitations. Passive and active methods for droplet formation are discussed, as well as the manipulation of droplet shape and content. This review also highlights the potential applications of droplet microfluidics in tissue engineering, cancer therapy, and drug delivery systems. The use of microfluidics in the production of lipid nanoparticles and polymeric microparticles is also presented, with emphasis on their potential in drug delivery and biomedical research. Finally, the contributions of microfluidics to vaccines, gene therapy, personalized medicine, and future perspectives are discussed, emphasizing the need for continuous innovation and integration with other technologies, such as AI and wearable devices, to further enhance its potential in personalized medicine and drug delivery. However, it is also noted that challenges in commercialization and widespread adoption still need to be addressed.

Keywords: biomedical applications; future perspectives; gene delivery; lipid nanoparticles; mRNA vaccines; microfluidic droplet generation; microfluidics; scale‐up.

PubMed Disclaimer

Similar articles

References

    1. R. O. Rodrigues, R. Lima, H. T. Gomes, and A. M. T. Silva, “Polymer Microfluidic Devices: An Overview of Fabrication Methods,” U.Porto Journal of Engineering 1, no. 1 (2015): 67–79, https://doi.org/10.24840/2183‐6493_001.001_0007.
    1. S. C. Terry, J. H. Jerman, and J. B. Angell, “A Gas Chromatographic Air Analyzer Fabricated on a Silicon Wafer,” IEEE Transactions on Electron Devices 26, no. 12 (1979): 1880–1886, https://doi.org/10.1109/T‐ED.1979.19791.
    1. N. Convery and N. Gadegaard, “30 Years of Microfluidics,” Micro and Nano Engineering 2, no. May (2019): 76–91, https://doi.org/10.1016/j.mne.2019.01.003.
    1. P. Gravesen, J. Branebjerg, and O. S. Jensen, “Microfluidics‐a Review,” Journal of Micromechanics and Microengineering 3, no. 4 (1993): 168–182, https://doi.org/10.1088/0960‐1317/3/4/002.
    1. A. Alrifaiy, O. A. Lindahl, and K. Ramser, “Polymer‐Based Microfluidic Devices for Pharmacy,” Biology and Tissue Engineering. Polymers 4, no. 3 (2012): 1349–1398, https://doi.org/10.3390/polym4031349.

Publication types

LinkOut - more resources